RNA Vaccines Methods and Protocols /
| Autor corporatiu: | |
|---|---|
| Altres autors: | |
| Sumari: | XII, 389 p. 57 illus., 49 illus. in color. text |
| Idioma: | anglès |
| Publicat: |
New York, NY :
Springer US : Imprint: Humana,
2024.
|
| Edició: | 2nd ed. 2024. |
| Col·lecció: | Methods in Molecular Biology,
2786 |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/978-1-0716-3770-8 |
| Format: | Electrònic Llibre |
Taula de continguts:
- Introduction to RNA Vaccines Post COVID-19
- Self-Replicating RNA Derived from the Genomes of Positive Strand RNA Viruses
- Negative Strand RNA Virus Vectored Vaccines
- New Generation Self-Replicating RNA Vaccines Derived from Pestivirus Genome
- Trans-Amplifying RNA Vaccines Against Infectious Diseases: A Comparison with Non-Replicating and Self-Amplifying RNA
- Generation and Characterization of In Vitro Transcribed mRNA
- Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases
- Sequence-Optimized mRNA Vaccines Against Infectious Disease
- Design and Synthesis of Circular RNA Expression Vectors
- Electroporation of mRNA as a Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins
- A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Lab
- Messenger RNA Lipid-Based Nanoparticles: Optimization of Formulations in the Lab
- Plant Expression of Trans-Encapsidated Chimeric Viral Vaccines with Animal RNA Replicons: An Update
- Producing Plasmid DNA Template for Clinical Grade RNA Vaccine Manufacture
- Regulatory Considerations for Producing mRNA Vaccines for Clinical Trials
- Quality by Digital Design for Developing Platform RNA Vaccine Manufacturing Processes
- Nonclinical Safety Testing of RNA Vaccines.